Download PDF
Thromb Haemost 1998; 80(01): 148-154
DOI: 10.1055/s-0037-1615154
Rapid Communication
Schattauer GmbH

Binding of Human Single Chain Urokinase to Chinese Hamster Ovary Cells and Cloning of Hamster u-PAR[*]

Bruce Fowler
1   Departments of Vascular Biology
,
Nigel Mackman
1   Departments of Vascular Biology
2   Immunology, The Scripps Research Institute, La Jolla, CA
,
Robert J. Parmer
3   Department of Medicine, University of California and Veteran’s Affairs Medical Center, San Diego, CA, USA
,
Lindsey A. Miles
1   Departments of Vascular Biology
› Author AffiliationsThis work was performed during the tenure of Established Investigatorships from The American Heart Association to R.J.P. and N.M. and from the American Heart Association and SmithKline Beecham to L.A.M.
Further Information

Publication History

Received 25 November 1997

Accepted after revision 10 March 1998

Publication Date:
27 December 2017 (online)

    Permissions and Reprints

Summary

The plasminogen activator, urokinase (u-PA), interacts with the u-PA receptor (u-PAR) which results in enhanced plasminogen activation on cell surfaces. The u-PAR is comprised of three homologous domains of ~90 amino acids, defined by the pattern of disulfide bonds. Domain 1 (amino acids 1-87) binds the ligand. Within this domain, Y57, and a site between residues 47 and 53, have been suggested as ligand contact points. Intradomain interactions also contribute to the interaction of u-PA and u-PAR.

The interaction of u-PA with its receptor exhibits some species specifity. Previous studies have shown that human u-PA does not bind to the murine u-PAR and murine u-PA does not recognize human u-PAR. However, human u-PA does interact with bovine cells with high affinity. To further examine the interaction of the human ligand with the u-PAR of a different species, we characterized the binding of human 125I single chain u-PA (scu-PA) to hamster cells. Chinese Hamster Ovary (CHO) cells bound human scu-PA with high affinity and capacity (Kd = 1.13 ± 0.8 nM; B max = 5.45 ± 0.98 × 104 sites/cell). In ligand blotting with human 125I-scu-PA, major bands migrating with apparent Mr’s of 74, 49 and 38 kDa were observed. The cDNA of hamster u-PAR was cloned and a single 1.4 kb mRNA species identified in Northern blots of CHO cell RNA. For comparison, we also cloned u-PAR cDNA from human THP-1 cells. Our human sequence was identical to those published for U937 and endothelial cells. These sequences were aligned with the published sequences for the murine, bovine and rat u-PAR’s to obtain a consensus sequence for five species. The cysteine residues could be aligned for all species. Y57, which has been suggested as a ligand contact point was also conserved across species. In addition, 5 of the 7 amino acids between amino acids 47 and 53 were conserved in all species. Gly283, the most likely glycosylphosphatidyl inositol attachment site, was also conserved in all species. The conservation of these amino acid residues across all five species, attests to their importance in u-PAR function. In addition, the results of

* Portions of this manuscript were presented at the American Heart Association Meeting, New Orleans, LA, 1996.


 

  • References

  • 1 Ellis V, Scully MF, Kakkar VV. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. J Biol Chem 1989; 264: 2185-8.
    PubMedGoogle Scholar
  • 2 Ellis V, Behrendt N, Dano K. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J Biol Chem 1991; 266: 12752-8.
    PubMedGoogle Scholar
  • 3 Vassalli J-D, Baccino D, Belin D. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 1985; 100: 86-92.
    CrossrefPubMedGoogle Scholar
  • 4 Cubellis MV, Nolli ML, Cassani G, Blasi F. Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. J Biol Chem 1986; 261: 15819-22.
    PubMedGoogle Scholar
  • 5 Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986; 103: 2411-20.
    CrossrefPubMedGoogle Scholar
  • 6 Stoppelli P, Corti A, Soffientini A, Cassani G. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA 1985; 82: 4939-43.
    CrossrefPubMedGoogle Scholar
  • 7 Appella E, Robinson EA, Ullrich SJ, Stoppelli MP, Corti A, Cassani G, Blasi F. The receptor-binding sequence of urokinase. J Biol Chem 1987; 262: 4437-40.
    PubMedGoogle Scholar
  • 8 Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Dano K, Appella E, Blasi F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J 1990; 9: 467-74.
    PubMedGoogle Scholar
  • 9 Kristensen P, Eriksen J, Blasi F, Dano K. Two alternatively spliced mouse urokinase receptor mRNA’s with different histological localization in the gastrointestinal tract. J Cell Biol 1991; 115: 1763-71.
    CrossrefPubMedGoogle Scholar
  • 10 Krätzschmar J, Haendler B, Kojima S, Rifkin DB, Schleuning W-D. Bovine urokinase-type plasminogen activator and its receptor: Cloning and induction by retinoic acid. Gene 1993; 125: 177-83.
    CrossrefPubMedGoogle Scholar
  • 11 Reuning U, Little SP, Dixon EP, Johnstone EM, Bang NU. Molecular cloning of cDNA for the bovine urokinase-type plasminogen activator receptor. Thromb Res 1993; 72: 59-70.
    CrossrefPubMedGoogle Scholar
  • 12 Rabbani SA, Rajwans N, Achbarou A, Murthy KK, Goltzman D. Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoclasts. FEBS Lett 1994; 338: 69-74.
    CrossrefPubMedGoogle Scholar
  • 13 Behrendt N, Ronne E, Ploug M, Petri T, Lober D, Nielsen LS, Schleuning W-D, Blasi F, Appella E, Dano K. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem 1990; 265: 6453-60.
    PubMedGoogle Scholar
  • 14 Estreicher A, Wohlwend A, Belin D, Scleuning W, Vassalli JD. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J Biol Chem 1989; 264: 1180-9.
    PubMedGoogle Scholar
  • 15 Nielsen LS, Kellerman GM, Behrendt N, Picone R, Dano K, Blasi F. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. J Biol Chem 1988; 263: 2358-63.
    PubMedGoogle Scholar
  • 16 Barnathan ES, Kuo A, Karikó K, Rosenfeld L, Murray SC, Behrendt N, Ronne E, Weiner D, Henkin J, Cines DB. Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA. Blood 1990; 76: 1795-806.
    PubMedGoogle Scholar
  • 17 Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Dano K. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem 1991; 266: 7842-7.
    PubMedGoogle Scholar
  • 18 Pollanen JJ. The N-terminal domain of human urokinase receptor contains two distinct regions critical for ligand recognition. Blood 1993; 82: 2719-29.
    PubMedGoogle Scholar
  • 19 Ploug M, Rahbek-Nielsen H, Ellis V, Roepstorff P, Dano K. Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane. Evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction. Biochemistry 1995; 34: 12524-34.
    CrossrefPubMedGoogle Scholar
  • 20 Ploug M, Ellis V, Dano K. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor. Biochemistry 1994; 33: 8991-7.
    CrossrefPubMedGoogle Scholar
  • 21 Behrendt N, Ronne E, Dano K. Domain interplay in the urokinase receptor – Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains. J Biol Chem 1996; 271: 22885-94.
    CrossrefPubMedGoogle Scholar
  • 22 Higazi AAR, Mazar A, Wang JY, Quan N, Griffin R, Reilly R, Henkin J, Cines DB. Soluble human urokinase receptor is composed of two active units. J Biol Chem 1997; 272: 5348-53.
    CrossrefPubMedGoogle Scholar
  • 23 Riittinen L, Limongi P, Crippa MP, Conese M, Hernandez-Marrero L, Fazioli F, Blasi F. Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. FEBS Lett 1996; 381: 1-6.
    CrossrefPubMedGoogle Scholar
  • 24 Solberg H, Lober D, Eriksen J, Ploug M, Ronne E, Behrendt N, Dano K, Hoyer-Hansen G. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator. Eur J Biochem 1992; 205: 451-8.
    CrossrefPubMedGoogle Scholar
  • 25 Mignatti P, Mazzieri R, Rifkin DB. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol 1991; 113: 1193-202.
    CrossrefPubMedGoogle Scholar
  • 26 Reuning U, Bang NU. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. Arterioscler Thromb 1992; 12: 1161-70.
    CrossrefPubMedGoogle Scholar
  • 27 Moller LB, Ploug M, Blasi F. Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator. Eur J Biochem 1992; 208: 493-500.
    CrossrefPubMedGoogle Scholar
  • 28 Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985; 260: 4303-11.
    PubMedGoogle Scholar
  • 29 Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
    CrossrefPubMedGoogle Scholar
  • 30 Johnson DA, Gautsch JW, Sportsman JR, Elder JH. Improved technique utilizing nonfat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose. Gene Analysis Techniques 1984; 1: 3-8.
    CrossrefPubMedGoogle Scholar
  • 31 Maniatis T, Fritsch EF, Sambrook J. Electrophoresis of RNA through gels containing formaldehyde. In: Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory; 1989. 7 43-45.
    Google Scholar
  • 32 Virca G, Northemann W, Shiels BR, Widera G, Broome S. Simplified Northern blot hybridization using 5% sodium dodecyl sulfate. BioTechniques 1990; 8: 370-1.
    PubMedGoogle Scholar
  • 33 Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-9.
    CrossrefPubMedGoogle Scholar
  • 34 Sambrook J, Fritsh EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd Ed. New York: Cold Spring Harbor Laboratory 1989; 7: 43-5.
    PubMedGoogle Scholar
  • 35 Sanger F, Nicken S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7.
    CrossrefPubMedGoogle Scholar
  • 36 Munson PJ, Rodbard D. Ligand a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220-39.
    CrossrefPubMedGoogle Scholar
  • 37 Cheng D, Yu W, Han S, Li X, Li F, Hu B, Fang J, Huang C. High level expression of human prourokinase cDNA in Chinese hamster ovary cells. Chinese Journal of Biotechnology 1997; 9: 151-9.
    PubMedGoogle Scholar
  • 38 Bajpai A, Baker JB. Cryptic urokinase binding sites on human foreskin fibroblasts. Biochem Biophys Res Commun 1985; 133: 475-82.
    CrossrefPubMedGoogle Scholar
  • 39 Ploug M, Ronne E, Behrendt N, Jensen AL, Blasi F, Dano K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 1991; 266: 1926-33.
    PubMedGoogle Scholar
  • 40 Felez J, Miles LA, Plescia J, Plow EF. Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines. J Cell Biol 1990; 111: 1673-83.
    CrossrefPubMedGoogle Scholar
  • 41 Fowler BJ, Mackman N, Parmer RJ. et al. Molecular basis for the species specificity of single chain urokinase (Scu-PA) binding to the urokinase receptor (u-PAR). [Abstract] Circulation 1996; 94: I-512.
    PubMedGoogle Scholar
  • 42 Moller LB, Pöllänen J, Ronne E, Pedersen N, Blasi F. N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand. J Biol Chem 1993; 268: 11152-9.
    PubMedGoogle Scholar